Assyro AI

Orange Book product · Generic (ANDA)

AMMONIA N 13

AMMONIA N-13

Generic (ANDA)ANDA 203812TE APRX UCLA BIOMEDICAL
View AMMONIA N-13 familyOpen on FDA Orange Book

At a glance

Jun 27, 2013

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 27, 2013

    13 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

AMMONIA N-13

Strength

30mCi-300mCi/8ML (3.75-37.5mCi/ML)

Dosage form

INJECTABLE

Route

INTRAVENOUS

TE code

AP

Application

ANDA 203812

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AMMONIA N-13

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo